1
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Ushigome F, Takanaga H, Matsuo H, et al:
Human placental transport of vinblastine, vincristine, digoxin and
progesterone: contribution of P-glycoprotein. Eur J Pharmacol.
408:1–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
3
|
Marbeuf-Gueye C, Salerno M, Quidu P and
Garnier-Suillerot A: Inhibition of the P-glycoprotein- and
multidrug resistance protein-mediated efflux of anthracyclines and
calceinacetoxymethyl ester by PAK-104P. Eur J Pharmacol.
391:207–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
4
|
Teodori E, Dei S, Martelli C, Scapecchi S
and Gualtieri F: The functions and structure of ABC transporters:
implications for the design of new inhibitors of Pgp and MRP1 to
control multidrug resistance (MDR). Curr Drug Targets. 7:893–909.
2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Di Pietro A, Conseil G, Perez-Victoria JM,
et al: Modulation by flavonoids of cell multidrug resistance
mediated by P-glycoprotein and related ABC transporters. Cell Mol
Life Sci. 59:307–322. 2002.PubMed/NCBI
|
6
|
Chearwae W, Anuchapreeda S, Nandigama K,
Ambudkar SV and Limtrakul P: Biochemical mechanism of modulation of
human P-glycoprotein (ABCB1) by curcumin I, II, and III purified
from Turmeric powder. Biochem Pharmacol. 68:2043–2052. 2004.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Kitagawa S: Inhibitory effects of
polyphenols on p-glycoprotein-mediated transport. Biol Pharm Bull.
29:1–6. 2006. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Borowski E, Bontemps-Gracz MM and
Piwkowska A: Strategies for overcoming ABC-transporters-mediated
multidrug resistance (MDR) of tumor cells. Acta Biochim Pol.
52:609–627. 2005.PubMed/NCBI
|
9
|
Brinker AM, Ma J, Lipsky PE and Raskin I:
Medicinal chemistry and pharmacology of genus Tripterygium
(Celastraceae). Phytochemistry. 68:732–766. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Carter BZ, Mak DH, Schober WD, et al:
Triptolide induces caspase-dependent cell death mediated via the
mitochondrial pathway in leukemic cells. Blood. 108:630–637. 2006.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Yao GH, Luan JF, Ye D, et al: [Effects of
triptolide on proliferation and apoptosis of Jurkat cell line in
acute T lymphocytic leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
16:506–509. 2008.(In Chinese).
|
12
|
Lee KY, Chang W, Qiu D, Kao PN and Rosen
GD: PG490 (triptolide) cooperates with tumor necrosis factor-alpha
to induce apoptosis in tumor cells. J Biol Chem. 274:13451–13455.
1999. View Article : Google Scholar : PubMed/NCBI
|
13
|
Tang XY, Zhu YQ, Tao WH, Wei B and Lin XL:
Synergistic effect of triptolide combined with 5-fluorouracil on
colon carcinoma. Postgrad Med J. 83:338–343. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chang WT, Kang JJ, Lee KY, et al:
Triptolide and chemotherapy cooperate in tumor cell apoptosis. A
role for the p53 pathway. J Biol Chem. 276:2221–2227. 2001.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Qu XJ, Yang JL, Russell PJ and Goldstein
D: Changes in epidermal growth factor receptor expression in human
bladder cancer cell lines following interferon-alpha treatment. J
Urol. 172:733–738. 2004. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kim YK, Song YJ, Seo DW, et al: Reversal
of multidrug resistance by
4-chloro-N-(3-((E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)phenyl)benzamide
through the reversible inhibition of P-glycoprotein. Biochem
Biophys Res Commun. 355:136–142. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Xu D, Lu Q and Hu X: Down-regulation of
P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by
honokiol. Cancer Lett. 243:274–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Okamoto T, Izumi H, Imamura T, et al:
Direct interaction of p53 with the Y-box binding protein, YB-1: a
mechanism for regulation of human gene expression. Oncogene.
19:6194–6202. 2000. View Article : Google Scholar : PubMed/NCBI
|
19
|
Calatozzolo C, Gelati M, Ciusani E, et al:
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and
GST-pi in human glioma. J Neurooncol. 74:113–121. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Liscovitch M and Lavie Y: Cancer multidrug
resistance: a review of recent drug discovery research. IDrugs.
5:349–355. 2002.PubMed/NCBI
|
21
|
Perez-Tomas R: Multidrug resistance:
retrospect and prospects in anti-cancer drug treatment. Curr Med
Chem. 13:1859–1876. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ramkissoon SH, Patel PS, Taborga M and
Rameshwar P: Nuclear factor-kappaB is central to the expression of
truncated neurokinin-1 receptor in breast cancer: implication for
breast cancer cell quiescence within bone marrow stroma. Cancer
Res. 67:1653–1659. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Amiri KI and Richmond A: Role of nuclear
factor-kappa B in melanoma. Cancer Metastasis Rev. 24:301–313.
2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Bentires-Alj M, Barbu V, Fillet M, et al:
NF-kappaB transcription factor induces drug resistance through MDR1
expression in cancer cells. Oncogene. 22:90–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Yoshida N, Takagi A, Kitazawa H, Kawakami
J and Adachi I: Inhibition of P-glycoprotein-mediated transport by
extracts of and monoterpenoids contained in Zanthoxyli
fructus. Toxicol Appl Pharmacol. 209:167–173. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chen YW, Lin GJ, Chuang YP, et al:
Triptolide circumvents drug-resistant effect and enhances
5-fluorouracil antitumor effect on KB cells. Anticancer Drugs.
21:502–513. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Xu B, Guo X, Mathew S, et al: Triptolide
simultaneously induces reactive oxygen species, inhibits NF-kappaB
activity and sensitizes 5-fluorouracil in colorectal cancer cell
lines. Cancer Lett. 291:200–208. 2010. View Article : Google Scholar : PubMed/NCBI
|